Purchases and Sales Made in Q3 2022 in Anebulo Pharmaceuticals, Inc. (ANEB)
This table provides information about the institutional ownership of Anebulo Pharmaceuticals, Inc. (ANEB) during Q3 2022. The information is specifically focused on institutions that hold shares of Anebulo Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
22 Nw, LP
Seattle, WA |
BUY
|
- |
1.7M+ 50.66% |
$4.77M - $9.35M
|
5.07M
$8.21M
|
|
|
Nov 10, 2022
Q3 2022
|
Nantahala Capital Management, LLC
New Canaan, CT |
BUY
|
- |
511KNew |
$1.43M - $2.81M
|
511K
$828K
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
600New |
$1.68K - $3.29K
|
600
$972
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
189+ 2.65% |
$529 - $1.04K
|
7.33K
$11.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
17+ 85.0% |
$47.6 - $93.3
|
37
$59.9
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-14- 0.08% |
$39.2 - $76.9
|
17.3K
$28.1K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-128- 4.4% |
$358 - $703
|
2.78K
$4.51K
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-200- 2.73% |
$560 - $1.1K
|
7.13K
$11.6K
|
|
|
Nov 14, 2022
Q3 2022
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-25K- 13.79% |
$70K - $137K
|
156K
$253K
|
|
|
Oct 13, 2022
Q3 2022
|
Lvw Advisors, LLC
|
SELL
|
- |
-25K- 3.58% |
$70.1K - $137K
|
675K
$1.09M
|